SCHEMBL13932017

SCHEMBL13932017

CC(C)(C)Oc1ccc(C(C)(C)c2ccc(OC(=O)C(C)(C)C)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ELANE P08246 16/20 0.59
PRTN3 P24158 2/20 0.42
ESR1 P03372 1/20 0.41
CYP3A4 P08684 1/20 0.41
AR P10275 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR6 P50406 1/20 0.41
ESRRG P62508 1/20 0.41
SLC6A3 Q01959 1/20 0.41
ESR2 Q92731 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24667224 0.91 ELANE (0.70) ELANEPRTN3ALDH1A1
SCHEMBL17678829 0.91 ELANE (0.70) ELANEPRTN3ESR1CYP3A4AR
SCHEMBL4758991 0.89 ELANE (0.47) ELANEPRTN3ALDH1A1
SCHEMBL19557785 0.86 ELANE (0.81) ELANEPRTN3ALDH1A1
SCHEMBL15397427 0.86 ELANE (0.63) ELANEPRTN3ESR1CYP3A4AR
SCHEMBL16677059 0.86 ELANE (0.63) ELANEPRTN3HSD17B10ALDH1A1
SCHEMBL19020532 0.86 ELANE (0.69) ELANEPRTN3ESR1CYP3A4AR
SCHEMBL21253991 0.84 LMNA (0.50) ELANEESR1CYP3A4ARSLC6A2
SCHEMBL15706819 0.84 ELANE (0.61) ELANEPRTN3ESR1CYP3A4AR
SCHEMBL22456974 0.84 ELANE (0.56) ELANEPRTN3ESR1ESR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240218117-A1 POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES Visolis, Inc. 2024-07-04 US disclosed
US-20230288847-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJIFILM BUSINESS INNOVATION CORP. (JP) 2023-09-14 US disclosed
US-11718747-B2 Nanoparticle containing compositions EVONIK OPERATIONS GMBH (DE) 2023-08-08 US disclosed
US-20230235254-A1 SUBSTRATE CLEANING SOLUTION, AND USING THE SAME, METHOD FOR MANUFACTURING CLEANED SUBSTRATE AND METHOD FOR MANUFACTURING DEVICE MERCK PATENT GMBH (DE) 2023-07-27 US disclosed
US-20220076941-A1 SUBSTRATE PROCESSING METHOD SCREEN Holdings Co., Ltd. (JP) 2022-03-10 US disclosed
EP-3954729-A1 FILM, LAMINATE, THERMOFORMED BODY, IN-MOLD MOLDING, METHOD FOR PRODUCING MOLDING, AND METHOD FOR PRODUCING IN-MOLD MOLDING MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-02-16 EP disclosed
WO-2021132279-A1 RESIN COMPOSITION AND FILM 株式会社カネカ 2021-07-01 WO disclosed
WO-2021045027-A1 POLYCARBONATE RESIN COMPOSITION 三菱瓦斯化学株式会社 2021-03-11 WO disclosed
WO-2020209211-A1 FILM, LAMINATE, THERMOFORMED BODY, IN-MOLD MOLDING, METHOD FOR PRODUCING MOLDING, AND METHOD FOR PRODUCING IN-MOLD MOLDING 三菱瓦斯化学株式会社 2020-10-15 WO disclosed
WO-2020188962-A1 RESIN COMPOSITION, MOLDED ARTICLE AND FILM 三菱瓦斯化学株式会社 2020-09-24 WO disclosed
WO-2020188961-A1 RESIN COMPOSITION, MOLDED ARTICLE, FILM AND METHOD FOR PRODUCING RESIN COMPOSITION 三菱瓦斯化学株式会社 2020-09-24 WO disclosed
US-20190055400-A1 Articles Of Manufacture Using An Impact Performance Modified Melt Polycarbonate SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-02-21 US disclosed
US-9765184-B2 Polycarbonate and method of preparing the same LOTTE ADVANCED MATERIALS CO., LTD. (KR) 2017-09-19 US disclosed
US-20170137589-A1 METHODS OF MODIFYING SURFACES OF STRUCTURES USED IN THE MANUFACTURE OF A SEMICONDUCTOR DEVICE VIA FLUORINATION SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-05-18 US disclosed
US-20160130389-A1 POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES Visolis, Inc. 2016-05-12 US disclosed
EP-2589589-A1 TRIPHENYLAMINE DERIVATIVE Hodogaya Chemical Co., Ltd. (JP) 2013-05-08 EP disclosed
EP-2034337-A1 OPTICAL LENS Mitsubishi Gas Chemical Company, Inc. (JP) 2009-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130389-A1 POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES COASY, FASN, GGPS1 ELANE 3085/4885PRTN3 3723/4885ESR1 1441/4885
US-20240218117-A1 POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES COASY, FASN, GGPS1 ELANE 3085/4885PRTN3 3723/4885ESR1 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.